Changes to Medicare Part D that were passed as part of the 2022 Inflation Reduction Act, and take effect on Jan. 1, 2025, offer good news for Medicare recipients. The changes are especially welcome for people with high drug costs, including those with inflammatory arthritis (such as rheumatoid arthritis and psoriatic arthritis) or osteoporosis.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Arthritis Advisor
Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
